BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.8 EUR
0.72%
Market Closed
Updated:
May 2, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-10.7
Current
-20
Median
13.5
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-10.7
Enterprise Value
/
61.2m
EBITDA
-5.7m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| DE |
|
BRAIN Biotech AG
XETRA:BNN
|
61.2m EUR | -10.7 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 10.7 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
77.1B USD | 20.4 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
64.2B USD | 23.2 | |
| CH |
|
Sika AG
SIX:SIKA
|
42.2B CHF | 21.7 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
36.4B CHF | 27.3 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
279.8B CNY | 17.8 | |
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
33.7B USD | 13.6 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.8T INR | 35.1 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
30.7B USD | 12.6 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.1B EUR | 33.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
11.5
2-Years Forward
EV/EBITDA
6.2
3-Years Forward
EV/EBITDA
3.4
You don't have any saved screeners yet
